About Us
Focusing on the process development and synthesis of innovative drug intermediates and high-end generic drug raw materials
Company Profile
Ruichen Kangda Biopharmaceutical (Wuhan) Co., Ltd. was registered and established in August 2018 in Donghu High tech Development Zone, Wuhan. The company has a strong R&D team led by several senior overseas returnees and PhDs. The core team mostly has many years of work experience in large pharmaceutical R&D enterprises and has mature drug development and marketing capabilities.
The company focuses on the synthesis of innovative drug intermediates, process development and synthesis of high-end generic drug raw materials, and synthesis of functional new materials. Adhering to the core concept based on synthetic chemistry, we are committed to developing new processes and methods, building products in a green and efficient manner, and solving the problems of product accessibility from 0 to 1 and efficient product acquisition from 1 to 100. At present, the company relies on its strong chemical synthesis capabilities and conducts research and development of new processes and methods to achieve efficient synthesis of differentiated products at a greener and lower cost, breaking the existing technological monopoly and better meeting market demand. Therefore, the large-scale production of multiple products has been successfully completed. In addition, based on common technologies, the company has successfully developed multiple independently initiated projects such as polysaccharide drugs, metal sugar complexes, and solubilization degradable materials, with extremely broad market prospects.
Ruichen Kangda Biopharmaceutical (Wuhan) Co., Ltd. will continuously explore and advance in the field of biomedicine with its strong research and innovation capabilities, contribute to the development of the industry, and create more value for human health.
SAF Coolest v1.3 设置面板 GAGSD-ZGYF-JSZDE-ZXQ
无数据提示
Sorry, the current column has no content for the time being.!
You can view other columns or returnHome Page